Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hohaus, S
Right arrow Articles by Leone, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hohaus, S
Right arrow Articles by Leone, G
Haematologica, Vol 89, Issue 6, 751-752
Copyright © 2004 by Ferrata Storti Foundation

Clinical Trial

Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma

S Hohaus, A Di Febo, S Storti, L Teofili, MT Voso, and G Leone

We report treatment results obtained with a modified Stanford V regimen in 32 patients with advanced Hodgkin's lymphoma (stage II bulky disease, III, IV). Treatment results were not superior to those achieved with conventional treatment (ABVD) in terms of complete remission and survival rates (progression-free survival and overall survival at 3 years: 66% and 91%, respectively).




HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2004 by the Ferrata Storti Foundation.